Today: 24 January 2026
Subscribe
Browse Category

Investments News 9 January 2026

MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

New York, Jan 9, 2026, 14:10 EST — Regular session MakeMyTrip Limited (MMYT.O) shares fell 4.5% to $78.78 in afternoon trading on Friday, after touching an intraday high of $83.42 and then sliding to as low as $78.37. The stock opened at $82.64 and had traded about 577,000 shares by mid-session. The drop puts the stock on course for its…
9 January 2026
···
CoreWeave stock rises after insiders disclose $21 million in share sales

CoreWeave stock rises after insiders disclose $21 million in share sales

New York, Jan 9, 2026, 13:19 EST — Regular session CoreWeave shares rose nearly 3% on Friday, extending a choppy start to the year for the AI cloud firm, after filings showed its chief executive and a top lieutenant sold about $20.7 million worth of stock earlier this week. (SEC) The sales matter because CoreWeave is still a relatively new…
9 January 2026
····
Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

New York, January 9, 2026, 13:01 EST — Regular session Immunome, Inc. shares jumped on Friday, outpacing a firmer biotech tape. The Nasdaq-listed stock (IMNM) was up 7.4% at $21.97, after trading between $20.71 and $22.00. The move keeps attention on Immunome’s lead drug, varegacestat, being developed for desmoid tumors — non-cancerous growths in connective tissue that can still be…
9 January 2026
····
Lumentum stock slips in choppy trade as Wall Street lifts targets to $455-$470

Lumentum stock slips in choppy trade as Wall Street lifts targets to $455-$470

New York, Jan 9, 2026, 13:01 EST — Regular session Shares of Lumentum Holdings Inc (LITE) were down 2.4% at $339.88 by early afternoon on Friday, pulling back after a violent week for the optical components maker. The stock has traded between $334.01 and $362.63 so far, with about 3.7 million shares changing hands. The move matters now because Lumentum…
9 January 2026
····
Sandisk stock jumps as report flags potential doubling of enterprise NAND prices

Sandisk stock jumps as report flags potential doubling of enterprise NAND prices

New York, Jan 9, 2026, 12:23 EST — Regular session Sandisk Corp shares rose 9.9% to $367.53 by midday Friday, a sharp rebound after a choppy start to the year for memory and storage names. The move followed a report that flagged a possible jump in prices for enterprise flash components. (Seeking Alpha) Why it matters now: pricing is the…
9 January 2026
····
AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

NEW YORK, Jan 9, 2026, 12:28 PM EST — Regular session AbbVie Inc (ABBV) shares fell about 0.8% in midday New York trade on Friday after the drugmaker trimmed its 2025 profit outlook and brushed off a report tying it to a takeover of cancer biotech Revolution Medicines. The stock was down $1.78 at $222.35. AbbVie said in an emailed…
9 January 2026
····
Western Digital stock bounces as Fidelity discloses 10.1% stake; eyes turn to Jan. 22 earnings

Western Digital stock bounces as Fidelity discloses 10.1% stake; eyes turn to Jan. 22 earnings

NEW YORK, January 9, 2026, 12:11 (EST) — Regular trading session Western Digital Corp shares climbed Friday after a regulatory filing showed Fidelity’s FMR LLC owned more than 10% of the data storage maker. The broader storage group also bounced back following Thursday’s pullback. Western Digital was up 1.7% at $190.87 as of 12:11 p.m. EST. The move follows Western…
9 January 2026
····
Liquidia stock jumps nearly 15% after Yutrepia sales update, cash-flow claim

Liquidia stock jumps nearly 15% after Yutrepia sales update, cash-flow claim

New York, Jan 9, 2026, 11:53 EST — Regular session Liquidia Corp shares jumped nearly 15% in morning trading on Friday after the drugmaker posted preliminary full-year figures for its newly launched pulmonary drug, easing near-term worries about demand and cash use. The move matters because Yutrepia is Liquidia’s main growth engine, and the stock has been trading like a…
9 January 2026
····
Bloom Energy stock jumps again as $2.65B AEP fuel-cell order keeps Wyoming data-center trade in focus

Bloom Energy stock jumps again as $2.65B AEP fuel-cell order keeps Wyoming data-center trade in focus

NEW YORK, Jan 9, 2026, 11:26 EST — Regular session Bloom Energy Corp shares rose 3.6% to $126.23 in late morning trading after hitting an earlier high of $129.96. The session low was $120.62. The move comes after American Electric Power disclosed that its unit will exercise a substantial portion of its option for Bloom’s solid oxide fuel cells —…
9 January 2026
····
Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

New York, Jan 9, 2026, 11:27 EST — Regular trading Eli Lilly and Company (LLY) shares were down about 0.4% at $1,081 in morning trade on Friday. The drugmaker said this week it will buy autoimmune developer Ventyx Biosciences for $1.2 billion in cash, bringing oral candidates for inflammatory bowel disease into its pipeline. The $14-a-share offer is slated to…
9 January 2026
····
Applied Digital stock jumps again as hyperscaler talks and $2.35B financing keep APLD in play

Applied Digital stock jumps again as hyperscaler talks and $2.35B financing keep APLD in play

NEW YORK, Jan 9, 2026, 11:16 EST — Regular session Applied Digital Corp shares rose about 11% to $35.38 on Friday, extending a post-earnings run for the AI data center developer as investors focused on new customer talks and the company’s funding stack. Broader U.S. equities were modestly higher. The move matters because Applied Digital is trying to turn signed…
9 January 2026
···
1 … 18 19 20 21 22 … 65

Stock Market Today

  • TransAlta (TSX:TA) Valuation Reviewed Amid Share Price Decline
    January 23, 2026, 11:41 PM EST. TransAlta (TSX:TA) has seen its share price fall nearly 28% over 90 days, currently trading at CA$17.41, prompting fresh valuation scrutiny. Despite short-term weakness, a five-year total shareholder return of 69.31% highlights longer-term gains. Analysts estimate a fair value of approximately CA$24.27 based on future cash flow growth linked to renewable energy projects and asset optimization. The stock trades at 2.1 times sales, exceeding a fair 1.0 times benchmark but below sector peers, raising questions about growth justification. Risks include potential disruptions in data center contracts and carbon pricing changes. Investors are weighing the under-valuation signal against the premium sales ratio amid evolving market conditions.
Go toTop